Cancer-specific chemotherapeutic strategy based on the vitamin K3 mediated ROS regenerative feedback and visualized drug release in vivo.

[1]  L. Ji,et al.  Three-in-One Self-Assembled Nanocarrier for Dual-Drug Delivery, Two-Photon Imaging, and Chemo-Photodynamic Synergistic Therapy. , 2018, ACS applied materials & interfaces.

[2]  Ziyang Cao,et al.  ROS-Sensitive Polymeric Nanocarriers with Red Light-Activated Size Shrinkage for Remotely Controlled Drug Release , 2018 .

[3]  M. Vendrell,et al.  Quinone-based fluorophores for imaging biological processes. , 2018, Chemical Society reviews.

[4]  Zhuxian Zhou,et al.  A Tumor‐Specific Cascade Amplification Drug Release Nanoparticle for Overcoming Multidrug Resistance in Cancers , 2017, Advanced materials.

[5]  Jonathan Rasmussen,et al.  ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy , 2017, Advanced materials.

[6]  Mengyun Peng,et al.  A positive feedback strategy for enhanced chemotherapy based on ROS-triggered self-accelerating drug release nanosystem. , 2017, Biomaterials.

[7]  A. Kajdacsy-Balla,et al.  Vitamin K and its analogs: Potential avenues for prostate cancer management , 2017, Oncotarget.

[8]  Shaobing Zhou,et al.  A Step‐by‐Step Multiple Stimuli‐Responsive Nanoplatform for Enhancing Combined Chemo‐Photodynamic Therapy , 2017, Advanced materials.

[9]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[10]  Liangzhu Feng,et al.  Light‐Responsive, Singlet‐Oxygen‐Triggered On‐Demand Drug Release from Photosensitizer‐Doped Mesoporous Silica Nanorods for Cancer Combination Therapy , 2016 .

[11]  Won Jong Kim,et al.  Reactive‐Oxygen‐Species‐Responsive Drug Delivery Systems: Promises and Challenges , 2016, Advanced science.

[12]  Xian‐Zheng Zhang,et al.  Acidity‐Triggered Tumor‐Targeted Chimeric Peptide for Enhanced Intra‐Nuclear Photodynamic Therapy , 2016 .

[13]  H. Tian,et al.  Dual-channel NIR activatable theranostic prodrug for in vivo spatiotemporal tracking thiol-triggered chemotherapy† †Electronic supplementary information (ESI) available: Detailed experimental procedures, characterizations, supplementary optical spectra and figures. See DOI: 10.1039/c6sc00970k , 2016, Chemical science.

[14]  Jun Wang,et al.  Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy , 2016, Proceedings of the National Academy of Sciences.

[15]  Zhuxian Zhou,et al.  Fusogenic Reactive Oxygen Species Triggered Charge‐Reversal Vector for Effective Gene Delivery , 2016, Advanced materials.

[16]  Zhuxian Zhou,et al.  Gene Delivery: Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery (Adv. Mater. 9/2016). , 2016, Advanced materials.

[17]  D. Cui,et al.  Near-Infrared Light Triggered ROS-activated Theranostic Platform based on Ce6-CPT-UCNPs for Simultaneous Fluorescence Imaging and Chemo-Photodynamic Combined Therapy , 2016, Theranostics.

[18]  Lucas A Lane,et al.  Stimuli-responsive nanoparticles for targeting the tumor microenvironment. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[19]  M. Alaibac,et al.  Vitamins and Melanoma , 2015, Cancers.

[20]  Xian‐Zheng Zhang,et al.  Dual‐Stage‐Light‐Guided Tumor Inhibition by Mitochondria‐Targeted Photodynamic Therapy , 2015 .

[21]  L. Ji,et al.  Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy. , 2014, Chemical communications.

[22]  Youyong Yuan,et al.  Conjugated-polyelectrolyte-based polyprodrug: targeted and image-guided photodynamic and chemotherapy with on-demand drug release upon irradiation with a single light source. , 2014, Angewandte Chemie.

[23]  Anzar Khan,et al.  Enzyme-triggered cascade reactions and assembly of abiotic block copolymers into micellar nanostructures. , 2014, Journal of the American Chemical Society.

[24]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[25]  Mallory R Gordon,et al.  Multi-stimuli responsive macromolecules and their assemblies. , 2013, Chemical Society reviews.

[26]  R. Zhuo,et al.  Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery. , 2013, Journal of the American Chemical Society.

[27]  Lucas H. Hofmeister,et al.  Physiologically relevant oxidative degradation of oligo(proline) cross-linked polymeric scaffolds. , 2011, Biomacromolecules.

[28]  José M. Morachis,et al.  Inflammation responsive logic gate nanoparticles for the delivery of proteins. , 2011, Bioconjugate chemistry.

[29]  Omid C Farokhzad,et al.  Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. , 2011, Accounts of chemical research.

[30]  Kyle E Broaders,et al.  A biocompatible oxidation-triggered carrier polymer with potential in therapeutics. , 2011, Journal of the American Chemical Society.

[31]  Didier Merlin,et al.  Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines. , 2010, Nature materials.

[32]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[33]  M. C. Stuart,et al.  Emerging applications of stimuli-responsive polymer materials. , 2010, Nature materials.

[34]  Ying Li,et al.  Dual redox responsive assemblies formed from diselenide block copolymers. , 2010, Journal of the American Chemical Society.

[35]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[36]  Takeshi Akiyoshi,et al.  The potential of vitamin K3 as an anticancer agent against breast cancer that acts via the mitochondria-related apoptotic pathway , 2009, Cancer Chemotherapy and Pharmacology.

[37]  Mauro Ferrari,et al.  Nanomedicine--challenge and perspectives. , 2009, Angewandte Chemie.

[38]  Jinming Gao,et al.  Efficacy of beta-lapachone in pancreatic cancer treatment: Exploiting the novel, therapeutic target NQO1 , 2005, Cancer biology & therapy.

[39]  Martin Müller,et al.  Oxidation-responsive polymeric vesicles , 2004, Nature materials.

[40]  D. Lamson,et al.  The anticancer effects of vitamin K. , 2003, Alternative medicine review : a journal of clinical therapeutic.

[41]  D. Siegel,et al.  NAD(P)H:Quinone Oxidoreductase Activity Is the Principal Determinant of β-Lapachone Cytotoxicity* , 2000, The Journal of Biological Chemistry.

[42]  K. S. Webb,et al.  A FACILE OXIDATION OF BORONIC ACIDS AND BORONIC ESTERS , 1995 .

[43]  A. Jaiswal,et al.  NAD(P)H:Quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues , 1993, Cancer and Metastasis Reviews.

[44]  L. Nutter,et al.  DNA strand scission and free radical production in menadione-treated cells. Correlation with cytotoxicity and role of NADPH quinone acceptor oxidoreductase. , 1992, The Journal of biological chemistry.

[45]  E. Mahmoud,et al.  Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide. , 2012, Journal of the American Chemical Society.